Timothy W. Trost
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Timothy W. Trost
Earlier roles on record: CFO at Werewolf Therapeutics, Inc. (HOWL) until February 13, 2026. Werewolf Therapeutics, Inc. reported in an 8-K filed February 13, 2026 that Timothy W. Trost resigned as Chief Financial Officer, effective February 13, 2026. The proxy statement of Werewolf Therapeutics, Inc. reports total compensation of $1,216,560 for Timothy W. Trost in fiscal 2024, including a base salary of $465,998. Disclosed compensation is on record for 3 fiscal years.
“the Company and each of Timothy W. Trost, Chief Financial Officer of the Company, and Dr. Randi Isaacs, M.D., Chief Medical Officer of the Company, agreed that Mr. Trost and Dr. Isaacs would resign as Chief Financial Officer and Chief Medical Officer, as applicable, effective February 13, 2026.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Start not stated–2026-02-13
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Werewolf Therapeutics, Inc. (HOWL) | Chief Financial Officer and Treasurer | $465,998 | $1,216,560 |
| 2023 | Werewolf Therapeutics, Inc. (HOWL) | Chief Financial Officer and Treasurer | $447,000 | $815,585 |
| 2021 | Werewolf Therapeutics, Inc. (HOWL) | Chief Financial Officer | $337,793 | $2,090,049 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.